Blog

Congestive heart failure in dogs and cats: causes, signs and workup

Congestive heart failure is the stage at which the heart no longer pumps adequately and fluid backs up into the lungs or body cavities. See the common causes in dogs and cats, warning signs, and how ECG, echocardiography, radiography and blood pressure guide the workup.

Congestive heart failure in dogs and cats: causes, signs and workup

Congestive heart failure (CHF) is the clinical stage at which an underlying heart disease has impaired the heart's ability to pump blood efficiently, causing fluid to back up (congestion) behind the affected chamber: typically pulmonary edema when the left side fails, and pleural effusion or ascites when the right side fails. It is not a disease in itself but the advanced consequence of a primary cardiac condition. In dogs, the most common cause is myxomatous mitral valve disease (chronic degeneration of the valve); in cats, cardiomyopathies predominate, above all the hypertrophic form. Diagnosis and staging are the responsibility of the attending veterinarian and combine physical examination with complementary tests (thoracic radiography, echocardiography, electrocardiography and blood pressure measurement), in line with veterinary cardiology consensus statements.

What congestive heart failure is

The word congestive describes the most visible part of the picture: blood that cannot move forward properly dams back, and the resulting high pressure pushes fluid out of the vessels. When the left side of the heart is overloaded, that fluid accumulates in the lungs (pulmonary edema), impairing gas exchange. When the right side is affected, congestion appears as pleural effusion (fluid around the lungs), ascites (fluid in the abdomen) or peripheral edema.

It is important to distinguish heart disease itself (for example, a leaking valve or a thickened muscle) from heart failure, which is the point at which that disease outpaces the body's compensatory mechanisms. Many animals live for months or years with preclinical cardiac disease, with no signs of congestion, and only develop CHF at a later stage. Detecting the disease before decompensation therefore changes how the patient is monitored.

Most common causes in dogs

In dogs, myxomatous mitral valve disease (MMVD, also called chronic degenerative valve disease or endocardiosis) is the most common acquired cardiac disease. The mitral valve, which separates the left chambers, undergoes progressive degeneration, stops closing completely and allows blood to leak backward. Over time this overloads the left atrium and ventricle and can progress to pulmonary edema. The ACVIM consensus guidelines describe a lettered staging system (A to D), spanning from the at-risk dog with no detectable disease to refractory heart failure, which guides when to begin monitoring and treatment.

Small, middle-aged to older breeds such as the Cavalier King Charles Spaniel, Dachshund, Poodle and other small dogs have a recognized predisposition. A physical-exam finding that often raises suspicion is a heart murmur, loudest over the left side of the chest. The presence of a murmur, however, indicates turbulent flow and does not by itself confirm heart failure: the stage is defined by complementary tests interpreted by the veterinarian. In dogs with already documented chamber enlargement but no signs of congestion yet, there is evidence that early initiation of therapy may prolong the preclinical phase, a decision that rests with the clinician.

Most common causes in cats

In cats, heart failure most often arises from cardiomyopathies, diseases of the heart muscle itself. Hypertrophic cardiomyopathy (HCM), characterized by thickening of the left ventricular wall, is the most common form. The ACVIM consensus statement on feline cardiomyopathies proposes classifying these diseases by phenotype (structure and function) and staging them, separating cats with subclinical disease into lower-risk and higher-risk groups for complications.

The major challenge in cats is that many have no audible murmur and no obvious signs until an acute decompensation. Beyond pulmonary edema and pleural effusion, cats with cardiomyopathy are at increased risk of arterial thromboembolism, in which a clot formed in the heart frequently lodges at the aortic bifurcation and causes sudden, painful paralysis of the hind limbs. This is an emergency. Hyperthyroidism and systemic arterial hypertension can also overload the feline heart and should be investigated by the veterinarian.

Signs that should raise the alarm

The signs of CHF reflect congestion and reduced cardiac performance. The most commonly reported are: increased rate or effort of breathing (dyspnea), rapid breathing at rest, coughing (more typical in dogs, often linked to left atrial enlargement), exercise intolerance, tiring easily, lethargy and, in advanced cases, fainting episodes (syncope), an abdomen distended by ascites, or bluish mucous membranes.

A useful, validated home-monitoring sign is the resting or sleeping respiratory rate: values persistently above roughly 30 breaths per minute in a relaxed animal warrant evaluation. In cats, coughing is uncommon, and open-mouth (panting) breathing usually indicates significant respiratory distress and is a reason to seek immediate care. Any animal with very labored breathing, pale or bluish gums, or sudden limb paralysis should be taken in as an emergency, without delay.

The role of each test in the workup

No single test makes the diagnosis of CHF; they complement one another. Thoracic radiography assesses the size of the cardiac silhouette and, above all, the presence of pulmonary edema or effusion, making it the test that most directly confirms congestion. Echocardiography is the cornerstone for defining the cause and severity: it measures the chambers, evaluates the valves and muscle, and distinguishes, for example, myxomatous mitral valve disease from cardiomyopathy. Blood pressure measurement detects systemic hypertension, which can cause or worsen cardiac overload, especially in cats. When it is unclear whether dyspnea is of cardiac or respiratory origin, biomarkers such as natriuretic peptides can aid triage, but they do not replace imaging, according to the literature.

The electrocardiogram (ECG) has a specific and irreplaceable role in assessing rhythm. It does not measure heart size or confirm congestion, but it is the test of choice for identifying and characterizing arrhythmias, a common finding in advanced cardiac disease, such as atrial fibrillation in dogs with markedly dilated atria, or tachyarrhythmias and blocks in cats with cardiomyopathy. In patients with syncope, episodic weakness or an irregular pulse, the ECG is essential. Connected electrocardiography technologies such as INcardio X (12-lead ECG), and automated blood pressure measurement by high-definition oscillometry such as BPScan, can support this data collection in practice and its sharing with specialists; interpretation and clinical decisions always remain the responsibility of the veterinarian.

When to refer to a cardiologist

Referral to a veterinary cardiologist or to a center with echocardiography is advisable when there are consistent signs of cardiac disease or CHF, and the decision is always clinical. Situations that often justify referral include: a new or progressive heart murmur, particularly in predisposed breeds; suspected chamber enlargement on radiographs; an arrhythmia detected on auscultation or ECG; syncope or exercise intolerance; any cat with cardiac suspicion, given the often silent course; and any animal already on treatment that decompensates.

When there are acute signs, severe dyspnea, open-mouth breathing in cats, bluish mucous membranes or sudden limb paralysis, emergency care takes priority over elective referral. The staging, treatment and monitoring approaches described here follow veterinary cardiology consensus statements, but this content is informational and does not replace an in-person evaluation: diagnosis, prescription and the follow-up plan are the responsibility of the veterinarian who examines the patient.

Sources

  1. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs (2019) PMID 30974015
  2. ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats (2020) PMID 32243654
  3. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial (2016) PMID 27678080
  4. Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 1--Cardiac diseases and pulmonary hypertension (2015) PMID 26040814